Regarding the tumor types, elevated PKM2 expression in tumor tissues predicted a worse OS in individuals with breast cancer, esophageal squamous cell cancer, gallbladder cancer and hepatocellular carcinoma. This evidence concerns the gene PKM and breast carcinoma.